Letter: Interpreting Trimethylamine N-Oxide in Acute Decompensated Heart Failure

Abstract

Get full access to this article

View all access options for this article.

References

Ceylan

Kaya

Saygın

Alp

HH.

Trimethylamine-N-oxide as a novel biomarker in acute decompensated heart failure: a comparative study with stable heart failure patients. Angiology. 2026;77(4):448-457.

Suzuki

Heaney

Bhandari

Jones

DJL

. Trimethylamine N-oxide and prognosis in acute heart failure. Heart. 2016;102:841-848.

Tang

WHW

Wang

Kennedy

, et al. Gut microbiota-dependent trimethylamine N-oxide pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116:448-455.

Koeth

Wang

Levison

, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576-585.

Tang

WHW

Wang

Levison

, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575-1584.

Wang

Levison

Hazen

Donahue

Hazen

SL.

Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal Biochem. 2014;455:35-40.

Savarese

Kishi

Vardeny

, et al. Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF). JACC Heart Fail. 2023;11:1-14.